On this page you'll find 10+ example sentences with Apellis. Discover how to use the word correctly in a sentence.
Apellis in a sentence
Using Apellis
- In the example corpus, apellis often appears in combinations such as: apellis pharmaceuticals, of apellis, in apellis.
Context around Apellis
- Average sentence length in these examples: 20.2 words
- Position in the sentence: 5 start, 13 middle, 1 end
- Sentence types: 19 statements, 0 questions, 0 exclamations
Corpus analysis for Apellis
- In this selection, "apellis" usually appears in the middle of the sentence. The average example has 20.2 words, and this corpus slice is mostly made up of statements.
- Around the word, raised and pharmaceuticals stand out and add context to how "apellis" is used.
- Recognizable usage signals include shares of apellis pharmaceuticals by and position in apellis pharmaceuticals by. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "apellis" sits close to words such as abdulai, abhinandan and abhor, which helps place it inside the broader word index.
Example types with apellis
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Apellis Pharmaceuticals () last posted its earnings results on Tuesday, November 5th. (11 words)
Morgan Stanley began coverage on Apellis Pharmaceuticals in a research note on Thursday, November 21st. (15 words)
Finally, BlackRock Inc. increased its position in Apellis Pharmaceuticals by 1.9% during the third quarter. (16 words)
Apellis is currently conducting a Phase 2 trial of APL-2 in four types of glomerular diseases in which complement has been implicated: C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis. (33 words)
Robert W. Baird reaffirmed an “outperform” rating and set a $81.00 target price on shares of Apellis Pharmaceuticals in a research note on Tuesday, February 6th. (27 words)
Hudson Bay Capital Management LP purchased a new stake in shares of Apellis Pharmaceuticals during the third quarter valued at approximately $476,000. (23 words)
Example sentences (19)
Apellis Pharmaceuticals, Inc. has a twelve month low of $19.83 and a twelve month high of $94.75.
Hudson Bay Capital Management LP purchased a new stake in shares of Apellis Pharmaceuticals during the third quarter valued at approximately $476,000.
Over 1 million people in the US and 5 million worldwide are affected by GA, providing a significant market opportunity for Apellis.
Vanguard Group Inc. raised its holdings in shares of Apellis Pharmaceuticals by 8.2% in the 1st quarter.
Apellis Pharmaceuticals () last posted its earnings results on Tuesday, November 5th.
Equities research analysts predict that Apellis Pharmaceuticals, Inc. will post -4.45 earnings per share for the current year.
Eventide Asset Management LLC purchased a new position in Apellis Pharmaceuticals in the fourth quarter valued at $12,558,000.
Finally, China Universal Asset Management Co. Ltd. boosted its holdings in shares of Apellis Pharmaceuticals by 29.3% in the third quarter.
First Horizon Advisors Inc. increased its position in shares of Apellis Pharmaceuticals by 69.0% in the third quarter.
Morgan Stanley began coverage on Apellis Pharmaceuticals in a research note on Thursday, November 21st.
Research analysts anticipate that Apellis Pharmaceuticals, Inc. will post -1.14 EPS for the current fiscal year.
Robert W. Baird reaffirmed an “outperform” rating and set a $81.00 target price on shares of Apellis Pharmaceuticals in a research note on Tuesday, February 6th.
Zacks Investment Research raised Apellis Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Wednesday, February 19th.
Finally, Bank of America Corp DE boosted its holdings in shares of Apellis Pharmaceuticals by 146.0% during the fourth quarter.
Finally, BlackRock Inc. increased its position in Apellis Pharmaceuticals by 1.9% during the third quarter.
SG Americas Securities LLC acquired a new position in shares of Apellis Pharmaceuticals in the 1st quarter valued at approximately $112,000.
SG Americas Securities LLC acquired a new stake in Apellis Pharmaceuticals in the 3rd quarter valued at about $1,585,000.
Sphera Funds Management LTD. increased its position in Apellis Pharmaceuticals by 91.8% in the 3rd quarter.
Apellis is currently conducting a Phase 2 trial of APL-2 in four types of glomerular diseases in which complement has been implicated: C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.
Common combinations with apellis
These word pairs occur most frequently in English texts:
- apellis pharmaceuticals 20×
- of apellis 7×
- in apellis 4×
- that apellis 2×